GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carmat (STU:CXT) » Definitions » Current Accrued Expense

Carmat (STU:CXT) Current Accrued Expense : €0.00 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Carmat Current Accrued Expense?

Carmat's Current Accrued Expense for the quarter that ended in Dec. 2024 was €0.00 Mil.


Carmat Current Accrued Expense Historical Data

The historical data trend for Carmat's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carmat Current Accrued Expense Chart

Carmat Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Carmat Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Carmat Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Carmat Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Carmat's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Carmat Business Description

Traded in Other Exchanges
Address
36, avenue de l’Europe, Immeuble l’Etendard Energy III, Velizy Villacoublay, FRA, 78140
Carmat is a France-based company engaged in the development and production of heart prosthesis. It engages in the development of implantable orthotopic and biocompatible artificial heart organs for the treatment of heart failure patients. The company also develops the product's power supply system and its control and remote diagnosis systems.